Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

18.70
BATS BZX Real-Time Price
As of 10:58am ET
 -0.05 / -0.27%
Today’s Change
9.92
Today|||52-Week Range
19.98
+10.98%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close18.75
Today’s open18.75
Day’s range18.62 - 18.89
Volume22,558
Average volume (3 months)1,012,119
Market cap$2.6B
Dividend yield--
Data as of 10:58am ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-75.68%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book394.57

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.18+1.33%
BLUEbluebird bio Inc-1.09-1.52%
RDUSRadius Health Inc-0.08-0.14%
KITEKite Pharma Inc-0.59-1.08%
Data as of 10:59am ET, 09/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Search for Jobs